ADMA Biologics Inc vs Invesco DB Oil Fund — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Invesco DB Oil Fund trades at $21.06. The key difference: Invesco DB Oil Fund is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | DBO | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Commodities - Energy |
52-Week High | $20.38 | $23.80 |
52-Week Low | $7.60 | $11.98 |
Enterprise Value | $2.29B | — |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →